Table 1.

Participant Characteristics (N=60)

	All N=60	No adherence counseling during counseling period n=38	Any adherence counseling during counseling period n=22
Agea, mean (sd)	48 (7)	49 (6)*	45 (7)*
Gendera, (%)
Male	50	53	46
Racea, (%)
White	12	13	9
Black	42	42	41
Other	47	45	50
Ethnicitya, (%)
Hispanic	45	42	50
Educationa, (%)
Less than high school	12	11	14
High school (partial or completed)	63	61	68
College (partial or completed)	25	29	18
Marital statusa, (%)
Married / living with partner	45	45	46
Widowed / separated / divorced	28	26	32
Single	27	29	23
Employmenta, (%)
Employed	3	0	9
Unable to work / unemployed / other	97	100	91
Years of methadone maintenancea, median (IQR)	11 (5-17)	8 (5-20)	11 (7-15)
Years living with HIVa, median (IQR)	13 (9-17)	15 (9-19)	12 (9-13)
Antiretroviral adherenceb,c, mean (sd)	.72 (.29)	.78 (.24)*	.61 (.35)*
Viral loadb (log10 copies/ ml), mean (sd)	2.51 (1.03)	2.24 (.79)*	2.96 (1.21)*
Absolute CD4+ T cell countb, cells/mm3, median (IQR)	367 (192-512)	416 (212-598)*	253 (140-347)*

^aMeasured at STAR*DOT enrollment.

^bMeasured at conclusion of STAR*DOT 24 week intervention. These data are described because they are included in the linear models to control for STAR*DOT intervention effects.

^cMeasured by pill count only.

^*p≤.05 for the comparison of those with no vs. any adherence counseling.